New £2.3m Trial to Test Personalised Pain Management for Endometriosis

A new £2.3 million study will investigate whether personalised pain management plans can improve quality of life for women with endometriosis, according to the BBC.

The trial will examine whether tailoring treatment approaches to individual patients, rather than relying on standard pain management protocols, can offer greater relief for those living with the condition.

Endometriosis occurs when tissue similar to the lining of the womb grows outside the uterus, often causing chronic pelvic pain, heavy periods and, in some cases, fertility difficulties. The condition affects an estimated one in ten women of reproductive age, though diagnosis is frequently delayed by years due to the varied and sometimes subtle nature of symptoms.

Researchers involved in the study hope that a more individualised approach to pain management could help address the wide variation in how endometriosis symptoms present and respond to treatment, given that current standard care does not work equally well for all patients.

The BBC's report did not detail the full trial protocol, the number of participants expected to take part, or the timeline for when results might be available, though studies of this kind typically run over multiple years to assess long-term outcomes.

Endometriosis has drawn increasing attention from health researchers and policymakers in recent years amid calls for greater investment in women's health conditions that have historically received comparatively less research funding relative to their prevalence and impact on quality of life.

Patient advocacy groups have long argued that better pain management options and faster diagnosis pathways could significantly ease the burden of the condition, which can affect work, relationships and mental health in addition to physical symptoms.